市場調查報告書
商品編碼
1392322
全球癌症治療市場新型藥物輸送系統研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測Global Novel Drug Delivery Systems in Cancer Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球癌症治療市場對新型藥物輸送系統的需求預計將從 2022 年的 144.8 億美元增至 2030 年的近 853.2 億美元,2023-2030 年研究期間CAGR為 24.82%。
癌症治療中的新型藥物輸送系統旨在以相對於身體其他部位增加特定部位藥物濃度的方式輸送藥物。新型藥物輸送系統 (NDDS) 透過減少給藥頻率提供更好的患者依從性。 NDDS對於癌症治療具有顯著的優勢,包括提高溶解度和生物利用度、降低毒性、最大治療效果、持續和受控的藥物輸送、提高穩定性以及更好的物理和生化分解安全性。
由於癌症治療的巨大益處,全球新型藥物傳輸系統在癌症治療市場上可能會擴大。此外,新型藥物輸送系統市場主要受到癌症發生率上升的影響。此外,開發新型藥物傳輸技術的研究活動增加,同時對正在進行的研究計畫的資助也有所增加。此外,用於癌症診斷和治療的醫療保健支出的增加可能會推動 NDDS 市場的成長。然而,高昂的治療成本可能會限制市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球癌症治療新型藥物傳輸系統市場的各個細分市場進行了包容性評估。癌症治療產業中新型藥物輸送系統的成長和趨勢為這項研究提供了整體方法。
本節涵蓋區域展望,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲癌症治療市場中新型藥物輸送系統當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。癌症治療市場新藥物輸送系統的主要參與者包括 Teva Pharmaceutical Industries Ltd.、Johnson & Johnson Services, Inc.、GALEN、Merrimack Pharmaceuticals Inc.、Shire、Samyang Biopharmaceuticals Corporation、Celgene Corporation、Spectrum Pharmaceuticals Inc.、BTG 。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Novel Drug Delivery Systems in Cancer Therapy Market is presumed to reach the market size of nearly USD 85.32 BN by 2030 from USD 14.48 BN in 2022 with a CAGR of 24.82% under the study period 2023 - 2030.
Novel drug delivery systems in cancer therapy aim to deliver medication in a manner that increases its concentration at a specific site relative to other parts of the body. A novel drug delivery system (NDDS) offers better patient compliance via the diminished frequency of dose. NDDS have significant advantages for cancer treatment, including improved solubility and bioavailability, reduced toxicity, maximum therapeutic effect, sustained and controlled drug delivery, increased stability and better security against physical and biochemical degradation.
The global novel drug delivery systems in the cancer therapy market are likely to expand due to substantial benefits for cancer treatment. Also, the novel drug delivery systems market is mainly influenced by a rise in the incidences of cancer. Moreover, rise in research activities for the development of technologies of novel drug delivery coupled with augmented funding for ongoing research projects. Furthermore, a rise in healthcare expenditure for the diagnosis and treatment of cancer is likely to propel the NDDS market growth. However, the high cost of therapy may limit the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of novel drug delivery systems in cancer therapy. The growth and trends of novel drug delivery systems in cancer therapy industry provide a holistic approach to this study.
This section of the novel drug delivery systems in cancer therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Novel Drug Delivery Systems in Cancer Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the novel drug delivery systems in cancer therapy market include Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., GALEN, Merrimack Pharmaceuticals Inc., Shire, Samyang Biopharmaceuticals Corporation, Celgene Corporation, Spectrum Pharmaceuticals Inc., BTG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.